bioMérieux is recognised as a global leader in in vitro diagnostics, providing innovative solutions to cell and gene therapy developers. This collaboration will leverage the strengths of both companies to develop innovative solutions and support the advanced therapy community in the Nordics. QVance, in addition to offering bioMérieux’s testing solutions, will offer an opportunity for customers to visit QVance’s site in Stockholm and see first hand bioMeriéux’s technology. Together, the companies will support the development of rapid and compliant quality control testing methods for advanced therapies in the Nordics. Read more in our press release.

Royale International is a quality driven organisation that provides tailored logistics solutions to its clients by means of experience, innovation and collaboration. This partnership marks a significant milestone in the development of end-to-end cold chain distribution and quality control analytical services solutions for the cell and gene therapy sector, combining Royale International’s extensive expertise in international shipping and logistics management with QVance’s innovative solutions in quality analytical services. Together, the two companies aim to address the need for personalised services for drug developers and manufacturers in the cold chain handling and release of cell and gene therapies across the Nordics and Europe. Read more in our press release.